Follow
Petra Marešová
Title
Cited by
Cited by
Year
Economics aspects of ageing population
P Marešová, H Mohelská, K Kuča
Procedia economics and finance 23, 534-538, 2015
632015
The potential of medical device industry in technological and economical context
P Maresova, M Penhaker, A Selamat, K Kuca
Therapeutics and clinical risk management 11, 1505, 2015
412015
Alzheimers disease: cost cuts call for novel drugs development and national strategy.
P Marešová, B Klímová, K Kuča
Ceska a Slovenska farmacie: casopis Ceske farmaceuticke spolecnosti a …, 2015
362015
Výzkum uplatnění znalostního managementu v českých podnicích
P Marešová
Technická univerzita v Liberci, 2010
272010
Deployment of cloud computing in small and medium sized enterprises in the Czech Republic
P Marešová, V Hálek
Economics and Management, 2014
262014
Knowledge management in Czech enterprises
P Maresova
E & M EKONOMIE A MANAGEMENT 13 (1), 131-144, 2010
262010
Měření ve znalostním managementu-aplikace metody Cost Benefit Analysis
P Marešová
Gaudeamus, 2012
242012
The economic burden of the care and treatment for people with Alzheimer’s disease: the outlook for the Czech Republic
P Marešová, V Zahálková
Neurological Sciences 37 (12), 1917-1922, 2016
192016
A comprehensive view on evaluation of cluster initiatives
V Bureš, V Jašíková, T Otčenášková, K Kolerová, V Zubr, P Marešová
Proceedings of the 8th European conference on management leadership and …, 2012
182012
Cost of treatment and care for people with Alzheimer’s disease: A Meta-Analysis
P Marešová, J Dolejs, H Mohelska, LK Bryan
Current Alzheimer Research 16 (14), 1245-1253, 2019
132019
Call for a uniform strategy of collecting Alzheimer’s disease costs: A review and meta-analysis
P Marešová, J Dolejš, K Kuca
Journal of Alzheimer's Disease 63 (1), 227-238, 2018
132018
Cooperation policy of rare diseases in the European Union
P Marešová, H Mohelská, K Kuča
Procedia-Social and Behavioral Sciences 171, 1302-1308, 2015
132015
Ethical Questions Linked to Rare Diseases and Orphan Drugs–A Systematic Review
J Kacetl, P Marešová, R Maskuriy, A Selamat
Risk management and healthcare policy 13, 2125, 2020
102020
Potential of ICT for Business in the Czech Republic
P Marešová
Professional Publishing, 2013
102013
Medical device development process, and associated risks and legislative aspects-systematic review
P Marešová, B Klímová, J Honegr, K Kuča, WNH Ibrahim, A Selamat
Frontiers in public health 8, 308, 2020
92020
Effective evaluation of cloud computing investment: application of cost benefit method analysis
P Marešová, V Soběslav
Technická univerzita v Liberci, 2017
92017
Onset of mortality increase with age and age trajectories of mortality from all diseases in the four nordic countries
J Dolejs, P Marešová
Clinical Interventions in Aging 12, 161, 2017
92017
Complexity stage model of the medical device development based on economic evaluation—MedDee
P Marešová, L Peter, J Honegr, L Režný, M Penhaker, M Augustýnek, ...
Sustainability 12 (5), 1755, 2020
82020
Application of the Cost Benefit Analysis method in Cloud Computing in the Czech Republic
P Marešová, K Půžová
Procedia-Social and Behavioral Sciences 109, 674-678, 2014
82014
Method for evaluating the performance of clusters in the Czech Republic
P Marešová, V Jašíková, M Trousil
Proceedings of the 2nd International Conference on Urban sustainability …, 2011
82011
The system can't perform the operation now. Try again later.
Articles 1–20